SNFCA.NASDAQSecurity National Financial CORP
Form 4: Security National Financial Insider Quist Reports Option Grants
Sentiment:
Insider Transaction Report
S. Andrew Quist, a Director, 10% Owner, and Vice President/General Counsel of Security National Financial Corp, reported the acquisition of 300,000 employee stock options.
Summary
- S. Andrew Quist, a Director, 10% Owner, and Vice President/General Counsel of Security National Financial Corp (snfca), reported the acquisition of new employee stock options.
- On December 5, 2025, Quist was granted options for 10,657 shares of Class C Common Stock at an exercise price of $9.38 per share, expiring on December 5, 2030.
- Also on December 5, 2025, Quist was granted options for 289,343 shares of Class C Common Stock at an exercise price of $8.53 per share, expiring on December 5, 2035.
- These newly granted options, totaling 300,000 shares, will vest quarterly in equal installments, beginning on March 5, 2026.
- The filing details a total beneficial ownership of 735,891 derivative securities (employee stock options) following these transactions.
- All reported options, including prior grants, have had their share amounts and exercise prices adjusted due to anti-dilution provisions of the 2013 Stock Option Plan and 2022 Equity Incentive Plan, reflecting various stock dividends paid between February 2017 and July 2025.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of insider stock option grants, which is a neutral event in itself. It reflects standard executive compensation practices and aligns management incentives with shareholder interests, without indicating any immediate positive or negative operational or financial performance.
Positives
- The acquisition of additional stock options by a key insider, who is also a Director, 10% Owner, and Vice President/General Counsel, indicates continued alignment of management's interests with long-term shareholder value.
- The vesting schedule for the new options provides a long-term incentive for the executive to contribute to the company's sustained performance.
Risks
- The value of the stock options is directly tied to the future market price of Security National Financial Corp's Class C and Class A Common Stock, meaning their value could decrease if the stock price declines.
- Exercise prices for some options are higher than others, implying that a significant increase in stock price would be required for all options to be 'in the money' and profitable.
Future Outlook
The newly granted stock options will begin vesting quarterly in equal installments starting on March 5, 2026, providing a future incentive for the executive. The options have expiration dates ranging from 2026 to 2035, aligning the executive's long-term interests with the company's performance.
Industry Context
This filing represents a routine insider transaction, specifically the grant of employee stock options, which is a common practice across industries to incentivize and retain key executives. The anti-dilution adjustments due to stock dividends are also standard provisions in many equity incentive plans, ensuring that option holders are not disadvantaged by such corporate actions.
Comparison to Industry Standards
- The use of stock options as a form of executive compensation is a widely adopted practice, comparable to compensation structures at many publicly traded companies across various sectors.
- The inclusion of anti-dilution provisions in the stock option plans (2013 Stock Option Plan and 2022 Equity Incentive Plan) aligns with best practices in corporate governance, protecting the value of executive equity incentives against dilution from stock dividends, similar to plans at companies like Apple (AAPL) or Microsoft (MSFT) which often include such clauses for their executive stock awards.
- The vesting schedule for the new options, quarterly installments starting in March 2026, is a common mechanism to encourage long-term commitment and performance, similar to vesting schedules seen in tech companies like Google (GOOGL) or financial institutions like JPMorgan Chase (JPM) for their executive equity grants.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Utilization | The stock option grants were made under the company's 2013 Stock Option Plan and 2022 Equity Incentive Plan, demonstrating ongoing use of these plans for executive compensation. | N/A | Reinforces the company's established framework for executive equity compensation and long-term incentive alignment. |
| Anti-Dilution Provisions | The share amounts and exercise prices of all options have been adjusted due to anti-dilution provisions within the stock option plans, reflecting various stock dividends paid by the company. | N/A | Ensures the economic value of the executive's stock options is preserved against dilution from stock dividends, maintaining the intended incentive. |
Related Party Transactions
- The acquisition of employee stock options by S. Andrew Quist, a Director, 10% Owner, and officer (Vice President/General Counsel), constitutes a related-party transaction as it involves compensation provided to a key insider.
Stakeholder Impact
- Shareholders: The grants align the interests of a key executive with shareholders by tying a significant portion of their potential compensation to the company's stock performance.
- Employees: The use of stock options as an incentive mechanism can signal a commitment to performance-based compensation, potentially influencing broader employee motivation and retention strategies.
Next Steps
- The newly granted stock options will begin vesting quarterly in equal installments starting on March 5, 2026.
- The reporting person may choose to exercise these options at their respective exercise prices before their expiration dates, which range from 2026 to 2035.
Key Dates
| Date | Description |
|---|---|
| 12/02/2016 | Grant date for 31,803 Class A Common Stock options at $4.32 exercise price. |
| 02/03/2017 | 5% stock dividend paid, affecting option 1. |
| 03/02/2017 | Exercisable date for 31,803 Class A Common Stock options. |
| 12/01/2017 | Grant date for 30,289 Class C Common Stock options at $3.27 exercise price. |
| 02/02/2018 | 5% stock dividend paid, affecting options 1 and 2. |
| 03/01/2018 | Exercisable date for 30,289 Class C Common Stock options. |
| 11/30/2018 | Grant date for 36,057 Class C Common Stock options at $3.76 exercise price. |
| 02/01/2019 | 5% stock dividend paid, affecting options 1, 2, and 3. |
| 02/28/2019 | Exercisable date for 36,057 Class C Common Stock options. |
| 02/07/2020 | 5% stock dividend paid, affecting options 1, 2, and 3. |
| 07/17/2020 | 2.5% stock dividend paid, affecting options 1, 2, and 3. |
| 07/16/2021 | 5% stock dividend paid, affecting options 1, 2, and 3. |
| 12/03/2021 | Grant date for 72,931 Class C Common Stock options at $7.02 exercise price. |
| 03/03/2022 | Exercisable date for 72,931 Class C Common Stock options. |
| 07/08/2022 | 5% stock dividend paid, affecting options 1, 2, 3, and 4. |
| 12/02/2022 | Grant date for 92,610 Class C Common Stock options at $5.56 exercise price. |
| 03/02/2023 | Exercisable date for 92,610 Class C Common Stock options. |
| 07/14/2023 | 5% stock dividend paid, affecting options 1, 2, 3, 4, and 5. |
| 12/01/2023 | Grant date for 88,200 Class C Common Stock options at $7.21 exercise price. |
| 03/01/2024 | Exercisable date for 88,200 Class C Common Stock options. |
| 07/12/2024 | 5% stock dividend paid, affecting options 1, 2, 3, 4, 5, and 6. |
| 12/06/2024 | Grant date for 7,298 Class C Common Stock options at $13.67 exercise price and 76,703 Class C Common Stock options at $12.43 exercise price. |
| 03/06/2025 | Exercisable date for 7,298 Class C Common Stock options and 76,703 Class C Common Stock options. |
| 07/18/2025 | 5% stock dividend paid, affecting all options. |
| 12/05/2025 | Date of earliest transaction reported in this filing; grant date for 10,657 Class C Common Stock options at $9.38 exercise price and 289,343 Class C Common Stock options at $8.53 exercise price. |
| 12/05/2025 | Transaction date for the acquisition of 10,657 and 289,343 Class C Common Stock options. |
| 03/05/2026 | Exercisable date for the 10,657 and 289,343 Class C Common Stock options granted on 12/05/2025, and start of quarterly vesting installments. |
| 12/02/2026 | Expiration date for 31,803 Class A Common Stock options. |
| 12/01/2027 | Expiration date for 30,289 Class C Common Stock options. |
| 11/30/2028 | Expiration date for 36,057 Class C Common Stock options. |
| 12/06/2029 | Expiration date for 7,298 Class C Common Stock options. |
| 12/05/2030 | Expiration date for 10,657 Class C Common Stock options. |
| 12/03/2031 | Expiration date for 72,931 Class C Common Stock options. |
| 12/02/2032 | Expiration date for 92,610 Class C Common Stock options. |
| 12/01/2033 | Expiration date for 88,200 Class C Common Stock options. |
| 12/06/2034 | Expiration date for 76,703 Class C Common Stock options. |
| 12/05/2035 | Expiration date for 289,343 Class C Common Stock options. |
| 12/31/2025 | Signature date of the reporting person. |
Keywords
Security National Financial Corp, SNFCA, SEC Form 4, Insider Trading, Stock Options, Employee Stock Option Plan, Corporate Governance, Executive Compensation, Beneficial Ownership, Derivative Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.